The Government has announced a new RSV Immunisation Pathfinder Programme in Ireland, offering a vaccine to 28,000 infants to reduce illnesses and hospitalizations caused by the virus. The initiative aims to prevent up to 453 hospitalizations and 48 ICU admissions based on evidence from a similar program in Spain. The program follows advice from the National Immunisation Advisory Committee and aims to protect young babies and safeguard healthcare capacity during the winter. HIQA is conducting Health Technology Assessments on RSV immunization to determine the most cost-effective strategy. The results will inform the development of a long-term RSV immunization program.
Source link
RSV vaccine to be offered to 28,000 infants this winter
